BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4020451)

  • 1. Pituitary apoplexy in an acromegalic patient during bromocriptine therapy. Case report.
    Alhajje A; Lambert M; Crabbé J
    J Neurosurg; 1985 Aug; 63(2):288-92. PubMed ID: 4020451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pituitary apoplexy in acromegaly during bromocriptine therapy.
    Yamaji T; Ishibashi M; Kosaka K; Fukushima T; Hori T; Manaka S; Sano K
    Acta Endocrinol (Copenh); 1981 Oct; 98(2):171-7. PubMed ID: 7293648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction in size of a pituitary tumor by bromocriptine therapy.
    McGregor AM; Scanlon MF; Hall K; Cook DB; Hall R
    N Engl J Med; 1979 Feb; 300(6):291-3. PubMed ID: 759882
    [No Abstract]   [Full Text] [Related]  

  • 4. Computed tomographic demonstration of the effects of bromocriptine on pituitary microadenoma size.
    Bonneville JF; Poulignot D; Cattin F; Couturier M; Mollet E; Dietemann JL
    Radiology; 1982 May; 143(2):451-5. PubMed ID: 7071347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of chronic bromocriptine administration on tumor size in patients with "nonsecreting" pituitary adenomas.
    Verde G; Oppizzi G; Chiodini PG; Dallabonzana D; Luccarelli G; Liuzzi A
    J Endocrinol Invest; 1985 Apr; 8(2):113-5. PubMed ID: 4031376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute effects of Parlodel-LAR and response to long-term treatment with bromocriptine in a patient with a follicle stimulating hormone-secreting pituitary adenoma.
    Abs R; Parizel PM; Beckers A
    J Endocrinol Invest; 1991 Feb; 14(2):135-8. PubMed ID: 1905737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of Forbes-Albright syndrome treated with CB-154: has the tumor really disappeared? (author's transl)].
    Kobayashi S; Shimura T; Nakazawa S
    No Shinkei Geka; 1980 May; 8(5):463-7. PubMed ID: 7383261
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of pituitary macroadenomas secreting PRL, HGH or ACTH with long-acting bromocriptine.
    Halperin I; Rodriguez MD; Cardenal C; Casamitjana R; Martinez Osaba MJ; Lienas V; Vilardell E
    J Endocrinol Invest; 1987 Jun; 10(3):277-82. PubMed ID: 3040850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopaminergic treatment of acromegaly: different effects on hormone secretion and tumor size.
    Oppizzi G; Liuzzi A; Chiodini P; Dallabonzana D; Spelta B; Silvestrini F; Borghi G; Tonon C
    J Clin Endocrinol Metab; 1984 Jun; 58(6):988-92. PubMed ID: 6725515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Size reduction of a nonfunctioning pituitary adenoma after bromocriptine therapy: case report].
    Takahashi T; Kuwayama A; Katoh T; Ichihara K; Kageyama N; Sasaki F
    No Shinkei Geka; 1984 Jan; 12(1):71-80. PubMed ID: 6717737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue kallikrein and the effect of bromocriptine in human prolactin and growth hormone-secreting pituitary adenomas.
    Jones TH; Figueroa CD; Smith CM; Bhoola KD
    Agents Actions Suppl; 1992; 38 ( Pt 2)():175-82. PubMed ID: 1462825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pituitary adenomas. An update on their management with an emphasis on the role of bromocriptine.
    Barrow DL; Tindall GT
    J Clin Neuroophthalmol; 1983 Dec; 3(4):229-37. PubMed ID: 6232287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congenital gigantism due to growth hormone-releasing hormone excess and pituitary hyperplasia with adenomatous transformation.
    Zimmerman D; Young WF; Ebersold MJ; Scheithauer BW; Kovacs K; Horvath E; Whitaker MD; Eberhardt NL; Downs TR; Frohman LA
    J Clin Endocrinol Metab; 1993 Jan; 76(1):216-22. PubMed ID: 8421089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Radiological control of prolactin adenomas treated with bromocriptine].
    Metzger J; Gardeur D; Pehuet M; Houlbert D
    Ann Med Interne (Paris); 1982; 133(1):59-60. PubMed ID: 7065592
    [No Abstract]   [Full Text] [Related]  

  • 15. Induction of apoptosis in rat somatotrophin-secreting pituitary adenoma cells by bromocriptine.
    Yin D; Kondo S; Takeuchi J; Morimura T
    Oncol Res; 1993; 5(9):383-7. PubMed ID: 8038459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and pathological effects of bromocriptine on prolactin-secreting and other pituitary tumors.
    Barrow DL; Tindall GT; Kovacs K; Thorner MO; Horvath E; Hoffman JC
    J Neurosurg; 1984 Jan; 60(1):1-7. PubMed ID: 6689702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pituitary apoplexy manifested during a bromocriptine test in a patient with a growth hormone- and prolactin-producing pituitary adenoma.
    Shirataki K; Chihara K; Shibata Y; Tamaki N; Matsumoto S; Fujita T
    Neurosurgery; 1988 Sep; 23(3):395-8. PubMed ID: 3226523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pregnancy in a subject with prolactin-secreting pituitary adenoma during therapy with bromocriptine].
    Passannanti G; Cardone A; Marafioti F; Alvino N
    Riv Ital Ginecol; 1980; 59 Suppl():87-91. PubMed ID: 7347889
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of bromocriptine treatment on the fibrous tissue content of prolactin-secreting and nonfunctioning macroadenomas of the pituitary gland.
    Esiri MM; Bevan JS; Burke CW; Adams CB
    J Clin Endocrinol Metab; 1986 Aug; 63(2):383-8. PubMed ID: 3722328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pituitary tumors.
    Ciric I
    Neurol Clin; 1985 Nov; 3(4):751-68. PubMed ID: 2867459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.